Insight Molecular Diagnostics Inc. (IMDX) stock
IMDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$1.78−0.08 (-4.30%)
Close on Nov 17, 2026Market cap $58.25MP/E –Yield –
Insight Molecular Diagnostics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Insight Molecular Diagnostics's profit margin for the twelve months ending Jun 30, 2026 was -2955.6%. For fiscal 2025 it was -1238.5%, against -3225.0% the year before. The highest annual figure on record is -1238.5% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1238.5% | +1986.5 |
| FY2024 | Dec 31, 2024 | -3225.0% | −1376.7 |
| FY2023 | Dec 31, 2023 | -1848.4% | +5761.4 |
| FY2022 | Dec 31, 2022 | -7609.8% | −4693.7 |
| FY2021 | Dec 31, 2021 | -2916.2% | −454.6 |
| FY2020 | Dec 31, 2020 | -2461.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -4711.3% | −2830.6 |
| Q1 FY2026 | Mar 31, 2026 | -13406.3% | −13094.2 |
| Q4 FY2025 | Dec 31, 2025 | -2015.4% | +239.8 |
| Q3 FY2025 | Sep 30, 2025 | -4174.6% | +7558.4 |
| Q2 FY2025 | Jun 30, 2025 | -1880.7% | +2475.1 |
| Q1 FY2025 | Mar 31, 2025 | -312.0% | +4874.9 |
| Q4 FY2024 | Dec 31, 2024 | -2255.1% | +2837.9 |
| Q3 FY2024 | Sep 30, 2024 | -11733.0% | −10220.5 |
| Q2 FY2024 | Jun 30, 2024 | -4355.8% | −2556.0 |
| Q1 FY2024 | Mar 31, 2024 | -5186.9% | −6208.1 |
| Q4 FY2023 | Dec 31, 2023 | -5093.0% | +11322.3 |
| Q3 FY2023 | Sep 30, 2023 | -1512.6% | +12417.3 |
| Q2 FY2023 | Jun 30, 2023 | -1799.8% | +1702.3 |
| Q1 FY2023 | Mar 31, 2023 | 1021.2% | +3729.4 |
| Q4 FY2022 | Dec 31, 2022 | -16415.3% | −15415.5 |
| Q3 FY2022 | Sep 30, 2022 | -13929.9% | −12527.4 |
| Q2 FY2022 | Jun 30, 2022 | -3502.1% | −2985.2 |
| Q1 FY2022 | Mar 31, 2022 | -2708.2% | −2359.5 |
| Q4 FY2021 | Dec 31, 2021 | -999.9% | +254.4 |
| Q3 FY2021 | Sep 30, 2021 | -1402.4% | −180.3 |
| Q2 FY2021 | Jun 30, 2021 | -516.9% | +5852.3 |
| Q1 FY2021 | Mar 31, 2021 | -348.7% | +47976.3 |
| Q4 FY2020 | Dec 31, 2020 | -1254.3% | – |
| Q3 FY2020 | Sep 30, 2020 | -1222.2% | – |
| Q2 FY2020 | Jun 30, 2020 | -6369.2% | – |
| Q1 FY2020 | Mar 31, 2020 | -48325.0% | – |
See a number that looks wrong?